Deutsche Bank Upgrades Edwards Lifesciences to Buy, Raises Price Target to $103
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Pito Chickering upgrades Edwards Lifesciences (EW) from Hold to Buy and increases the price target from $86 to $103.
May 14, 2024 | 4:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences was upgraded by Deutsche Bank from Hold to Buy, with a price target increase from $86 to $103, indicating a positive outlook on the stock.
The upgrade from Hold to Buy by a major bank like Deutsche Bank, accompanied by a significant increase in the price target, suggests a strong bullish sentiment towards Edwards Lifesciences. This is likely to positively influence investor perception and could lead to a short-term increase in the stock price, as market participants react to the upgraded outlook and higher price target.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100